Back to results
US 2010/0301277 A1Published application
Imidazole Derivatives and Their use as Dopants for Doping an Organic Semiconductor Matrix Material
AssigneeNovaled GmbH
InventorsHorst Hartmann, Olaf Zeika, Martin Ammann, Rene Dathe
Life of this patent
Estimating the term…
Abstract
The present invention relates to imidazole derivatives and their use as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements.
Claims11
Imidazole derivatives with the following formulae:
- wherein X is selected from the group consisting of substituted and non-substituted conjugated double-bond systems, substituted and non-substituted quinoid aromatic ring systems, and substituted and non-substituted quinoid anellated aromatic ring systems, substituted and non-substituted quinoid heteroaromatic ring systems, and substituted and non-substituted quinoid anellated heteroaromatic ring systems;
- Y is selected from the group consisting of 2-indandione derivatives, C(CN)2, NCN, O, 2-cyclopentadiene derivatives, 2-cyclopentendione derivatives, C(CF3)2, C(CN)aryl, C(CN)oligoaryl, C(CN)heteroaryl, C(CF3)aryl, C(CF3)oligoaryl, C(CF3)heteroaryl, N-aryl, N-heteroaryl, N-oligoaryl, acceptor-substituted aryl, and acceptor-substituted heteroaryl with more than six ring atoms;
- and
- R1-R4 are independently selected from the group consisting of hydrogen, substituted and unsubstituted aryls, substituted and unsubstituted heteroaryls, substituted and unsubstituted conjugated hydrocarbon chains with alternating C—C single and double bonds, halogen, cyano, pseudohalogen, nitro, halogenated or perhalogenated alkyls, carboxylic acids and derivatives thereof, and sulphonic acids and derivatives thereon;
- wherein at least one of R1-R4 is not hydrogen, or wherein two adjacent R1-R4 are elements of an aromatic ring system anellated to the imidazole ring.
2 more elements
An electronic or optoelectronic structural element comprising the imidazole derivatives represented by the following formulae:
- wherein X is selected from the group consisting of substituted and non-substituted conjugated double-bond systems, substituted and non-substituted quinoid aromatic ring systems, and substituted and non-substituted quinoid anellated aromatic ring systems, substituted and non-substituted quinoid heteroaromatic ring systems, and substituted and non-substituted quinoid alienated heteroaromatic ring systems;
- Y is selected from the group consisting of 2-indandione derivatives, C(CN)2, NCN, O, 2-cyclopentadiene derivatives, 2-cyclopentendione derivatives, C(CF3)2, C(CN)aryl, C(CN)oligoaryl, C(CN)heteroaryl, C(CF3)aryl, C(CF3)oligoaryl, C(CF3)heteroaryl, N-aryl, N-heteroaryl, N-oligoaryl, acceptor-substituted aryl, and acceptor-substituted heteroaryl;
- and
- R1-R8 are independently selected from the group consisting of hydrogen, substituted and unsubstituted aryls, substituted and unsubstituted heteroaryls, substituted and unsubstituted conjugated hydrocarbon chains with alternating C—C single and double bonds, halogen, cyano, pseudohalogen, nitro, halogenated or perhalogenated alkyls, carboxylic acids and derivatives thereof, and sulphonic acids and derivatives thereof;
- wherein at least one of R1-R8 is not hydrogen, or wherein two adjacent R1-R8 are elements of an aromatic ring system anellated to the imidazole ring.
2 more elements
Dependencies are inferred from the claim text.